Rituxan (rituximab) - Roche
Ras-associated autoimmune leukoproliferative disorder associated with immune thrombotic thrombocytopenic purpura. (PubMed, Res Pract Thromb Haemost) - Oct 6, 2026 - "The patient had four ADAMTS13 relapses, responsive to rituximab. This case highlights co-occurrence of RALD and iTTP, extending the spectrum of Ras-associated autoimmune cytopenias." 
Journal • Chronic Myelomonocytic Leukemia • Hematological Disorders • Hematological Malignancies • Immunology • Leukemia • Neutropenia • Oncology • Thrombocytopenia • Thrombocytopenic Purpura • KRAS • RAS
http://www.ncbi.nlm.nih.gov/pubmed/42830850
 
Andrew J Innes; Asad Luqmani; Elisabet Nadal-Melsio; Jane F Apperley; Marie Scully; Matthew A Carter; Monica Sen
 
Oct 6, 2026
 
Prev Next